Xtant Medical Holdings Inc (XTNT) — Capital Reinvestment Ratio
Latest as of December 2025:
0.07x
Xtant Medical Holdings Inc (XTNT) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow ($5.38 Million) in capital expenditures ($395.00K). See Xtant Medical Holdings Inc (XTNT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.07x
Capex / Operating Cash Flow
Operating Cash Flow
$5.38 Million
USD
Capital Expenditures
$395.00K
USD
Data as of
Dec 2025
Most recent filing
Xtant Medical Holdings Inc Capital Reinvestment Ratio (2018–2025)
This chart tracks Xtant Medical Holdings Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Xtant Medical Holdings Inc (2018–2025)
Year-by-year Capital Reinvestment Ratio for Xtant Medical Holdings Inc from 2018 to 2025. For live market cap and broader valuation context, see market value of Xtant Medical Holdings Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $12.55 Million | $2.38 Million | ▼ -96.1% |
| 2021 | 4.82x | $439.00K | $2.12 Million | ▲ +835.8% |
| 2018 | 0.51x | $1.21 Million | $624.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow